John Gonzales

Dry Eye Disease Therapies at a Crossroads—A Call for Reform

This Viewpoint discusses current approval pathways for dry eye disease medications and the need to advance the standard of evidence for these medications.

Time-Varying Effects of Valacyclovir Prophylaxis in the Zoster Eye Disease Study

Importance The Zoster Eye Disease Study (ZEDS) supports consideration of suppressive valacyclovir for 1 year to reduce risk of recurrent keratitis or iritis in patients with herpes zoster ophthalmicus (HZO). Although the primary outcome did not show benefit of suppressive valacyc...